Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.4
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Jun. 30, 2022
Current assets:    
Cash and cash equivalents $ 146,746 $ 150,410
Prepaid expenses and other 860 1,694
Total current assets 147,606 152,104
Right-of-use assets 2,294 152
Property and equipment, net 160 16
Deposits and other 148 148
Total assets 150,208 152,420
Current liabilities:    
Accounts payable 2,841 1,132
Accrued liabilities:    
Compensation and benefits 2,234  
Accrued clinical and other 1,071 979
Insurance premiums   243
Current portion of operating lease liabilities 167 108
Total current liabilities 6,313 2,462
Long term liabilities:    
Operating lease liabilities, net of current portion 2,196 80
Embedded derivative liabilities 434 407
Total liabilities 8,943 2,949
Commitments and contingencies (Notes 3, 4, 8 and 9)
Shareholders' equity:    
Preferred stock, $0.001 par value; 400 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value; 100,000 shares authorized; issued and outstanding 36,827 and 33,582 shares as of December 31, 2022 and June 30, 2022, respectively 37 34
Additional paid-in capital 373,813 358,635
Accumulated deficit (232,585) (209,198)
Total shareholders' equity 141,265 149,471
Total liabilities and shareholders' equity $ 150,208 $ 152,420